AK135 in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

December 31, 2027

Conditions

Chemotherapy-induced Peripheral Neuropathy (CIPN)

Interventions

DRUG

AK135

IV infusion, specified dose with specified treatment frequency

Trial Locations (2)

Sun Yat-sen Memorial Hospital, Guangzhou

Shanghai GoBroad Cancer Hospital, Shanghai